HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (29) Citing Articles via Google Scholar Google Scholar Articles by Mayr, M. Articles by Xu, Q. Search for Related Content PubMed PubMed Citation Articles by Mayr, M. Articles by Xu, Q.

Ischemic preconditioning exaggerates cardiac damage in PKC- null mice

¹Department of Cardiac and Vascular Sciences and ²Department of Basic Medical Sciences, St. George's Hospital Medical School, London SW17 0RE, United Kingdom; ³Division of Cardiology, Department of Internal Medicine, University Hospital Innsbruck, Innsbruck 6020, Austria; ⁴Max-Planck Institute for Experimental Endocrinology, Hannover 30625, Germany; and ⁵Proteome Sciences and ⁶Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom

Submitted 18 September 2003 ; accepted in final form 22 March 2004

Ischemic preconditioning confers cardiac protection during subsequent ischemia-reperfusion, in which protein kinase C (PKC) is believed to play an essential role, but controversial data exist concerning the PKC- isoform. In an accompanying study (26), we described metabolic changes in PKC- knockout mice. We now wanted to explore their effect on early preconditioning. Both PKC-^–/– and PKC-^+/+ mice underwent three cycles of 5-min left descending artery occlusion/5-min reperfusion, followed by 30-min occlusion and 2-h reperfusion. Unexpectedly, preconditioning exaggerated ischemia-reperfusion injury in PKC-^–/– mice. Whereas ischemic preconditioning increased superoxide anion production in PKC-^+/+ hearts, no increase in reactive oxygen species was observed in PKC-^–/– hearts. Proteomic analysis of preconditioned PKC-^+/+ hearts revealed profound changes in enzymes related to energy metabolism, e.g., NADH dehydrogenase and ATP synthase, with partial fragmentation of these mitochondrial enzymes and of the E₂ component of the pyruvate dehydrogenase complex. Interestingly, fragmentation of mitochondrial enzymes was not observed in PKC-^–/– hearts. High-resolution NMR analysis of cardiac metabolites demonstrated a similar rise of phosphocreatine in PKC-^+/+ and PKC-^–/– hearts, but the preconditioning-induced increase in phosphocholine, alanine, carnitine, and glycine was restricted to PKC-^+/+ hearts, whereas lactate concentrations were higher in PKC-^–/– hearts. Taken together, our results suggest that reactive oxygen species generated during ischemic preconditioning might alter mitochondrial metabolism by oxidizing key mitochondrial enzymes and that metabolic adaptation to preconditioning is impaired in PKC-^–/– hearts.

protein kinase C; proteomics; metabolomics; ischemia-reperfusion; mouse model

This article has been cited by other articles:

				T. Nguyen, M. Ogbi, and J. A. Johnson Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840. [Abstract] [Full Text] [PDF]

				M. Mayr Metabolomics: Ready for the Prime Time? Circ Cardiovasc Genet, October 1, 2008; 1(1): 58 - 65. [Full Text] [PDF]

				A. Redel, V. Jazbutyte, T. M. Smul, M. Lange, T. Eckle, H. Eltzschig, N. Roewer, and F. Kehl Impact of Ischemia and Reperfusion Times on Myocardial Infarct Size in Mice In Vivo Experimental Biology and Medicine, January 1, 2008; 233(1): 84 - 93. [Abstract] [Full Text] [PDF]

				D. Guo, T. Nguyen, M. Ogbi, H. Tawfik, G. Ma, Q. Yu, R. W. Caldwell, and J. A. Johnson Protein kinase C-{varepsilon} coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2219 - H2230. [Abstract] [Full Text] [PDF]

				M. C. Stuhlinger, E. Conci, B. J. Haubner, E.-M. Stocker, J. Schwaighofer, J. P. Cooke, P. S. Tsao, O. Pachinger, and B. Metzler Asymmetric Dimethyl L-Arginine (ADMA) is a critical regulator of myocardial reperfusion injury Cardiovasc Res, July 15, 2007; 75(2): 417 - 425. [Abstract] [Full Text] [PDF]

				M. Nishihara, T. Miura, T. Miki, J. Sakamoto, M. Tanno, H. Kobayashi, Y. Ikeda, K. Ohori, A. Takahashi, and K. Shimamoto Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3beta Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H748 - H755. [Abstract] [Full Text] [PDF]

				K. Inagaki, E. Churchill, and D. Mochly-Rosen Epsilon protein kinase C as a potential therapeutic target for the ischemic heart Cardiovasc Res, May 1, 2006; 70(2): 222 - 230. [Abstract] [Full Text] [PDF]

				M. Mayr, Y.-L. Chung, U. Mayr, X. Yin, L. Ly, H. Troy, S. Fredericks, Y. Hu, J. R. Griffiths, and Q. Xu Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2135 - 2142. [Abstract] [Full Text] [PDF]